Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decreasing Function01:27

Decreasing Function

243
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
243
Decreased Body Temperature01:29

Decreased Body Temperature

1.0K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.0K
Decreased pulse rate01:14

Decreased pulse rate

861
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
861
Inflammatory Response01:28

Inflammatory Response

16.2K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.2K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

7.6K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.6K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

16.2K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcription factor YALI1_A16891g contributes to enhanced glycolytic flux and mevalonate production at elevated temperature in engineered Yarrowia lipolytica.

Bioresource technology·2026
Same author

Data-driven optimization of salt shock for high-efficiency ectoine production in <i>Halomonas elongata</i>.

Synthetic and systems biotechnology·2026
Same author

Quantitative mechanism separation of single-event transients in nanosheet transistors via TCAD simulation.

Nanotechnology·2026
Same author

Exploring shared biomarkers and their mechanisms in thyroid cancer and systemic lupus erythematosus via bioinformatics analysis.

Discover oncology·2026
Same author

Effects of Resistance Training on Breast Cancer-Related Lymphedema: A Meta-Analysis.

Archives of rehabilitation research and clinical translation·2026
Same author

Investigating the Regulatory Role of Neuritin in TUBB3 Expression and Akt-mTOR Signaling Pathway in Gastric Cancer Cells.

Clinical laboratory·2026

Related Experiment Video

Updated: Jan 24, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.4K

Novel Piperazino-Enaminones Decrease Pro-inflammatory Cytokines Following Hemarthrosis in a Hemophilia Mouse Model.

Chen Zhong1, Doreen Szollosi2, Junjiang Sun3,4

  • 1Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.

Inflammation
|May 27, 2019
PubMed
Summary

Novel enaminone compounds (JODI) show promise in treating hemophilia arthropathy. JODI suppressed key inflammatory cytokines in a mouse model, offering a potential new therapy for joint damage caused by hemarthrosis.

Keywords:
cytokineshemarthrosishemophiliapiperazino-enaminonespro-inflammatory

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.2K
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1&#946; using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

27.0K

Related Experiment Videos

Last Updated: Jan 24, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.4K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.2K
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1&#946; using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

27.0K

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Hemarthrosis, bleeding into joints, is the main cause of hemophiliac arthropathy (HA).
  • Pro-inflammatory cytokines are implicated in HA pathogenesis, suggesting anti-cytokine therapies as potential treatments.
  • Enaminone compounds (JODI) with an N-aryl piperazino motif demonstrated in vitro reduction of pro-inflammatory cytokines.

Purpose of the Study:

  • To evaluate the efficacy of JODI in suppressing cytokines involved in joint inflammation.
  • To assess JODI's therapeutic potential in a mouse model of hemarthrosis.

Main Methods:

  • Assessed JODI's effect on survival following lipopolysaccharide (LPS) treatment.
  • Quantified cytokine and chemokine levels in a hemophilia mouse model with induced hemarthrosis.
  • Administered JODI to hemophilia mice to observe its effect on cytokine profiles.

Main Results:

  • JODI significantly improved survival rates after LPS challenge.
  • JODI administration led to a significant decrease in most pro-inflammatory cytokines and chemokines.
  • In hemophilia mice, JODI reversed hemarthrosis-induced changes in local cytokine profiles, including pro-inflammatory, pro-angiogenic, and anti-inflammatory cytokines.

Conclusions:

  • JODI effectively suppresses pro-inflammatory and pro-angiogenic cytokines while restoring anti-inflammatory cytokines.
  • JODI demonstrates therapeutic potential in managing hemophilia arthropathy by mitigating joint inflammation.
  • JODI represents a novel therapeutic approach for hemophilia arthropathy management.